Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

220 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Should we screen BRCA1 mutation carriers only with MRI? A multicenter study.
Obdeijn IM, Winter-Warnars GA, Mann RM, Hooning MJ, Hunink MG, Tilanus-Linthorst MM. Obdeijn IM, et al. Among authors: mann rm. Breast Cancer Res Treat. 2014 Apr;144(3):577-82. doi: 10.1007/s10549-014-2888-8. Epub 2014 Feb 25. Breast Cancer Res Treat. 2014. PMID: 24567197
Volumetric breast density affects performance of digital screening mammography.
Wanders JO, Holland K, Veldhuis WB, Mann RM, Pijnappel RM, Peeters PH, van Gils CH, Karssemeijer N. Wanders JO, et al. Among authors: mann rm. Breast Cancer Res Treat. 2017 Feb;162(1):95-103. doi: 10.1007/s10549-016-4090-7. Epub 2016 Dec 23. Breast Cancer Res Treat. 2017. PMID: 28012087 Free PMC article.
MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial.
Saadatmand S, Geuzinge HA, Rutgers EJT, Mann RM, de Roy van Zuidewijn DBW, Zonderland HM, Tollenaar RAEM, Lobbes MBI, Ausems MGEM, van 't Riet M, Hooning MJ, Mares-Engelberts I, Luiten EJT, Heijnsdijk EAM, Verhoef C, Karssemeijer N, Oosterwijk JC, Obdeijn IM, de Koning HJ, Tilanus-Linthorst MMA; FaMRIsc study group. Saadatmand S, et al. Among authors: mann rm. Lancet Oncol. 2019 Aug;20(8):1136-1147. doi: 10.1016/S1470-2045(19)30275-X. Epub 2019 Jun 17. Lancet Oncol. 2019. PMID: 31221620 Clinical Trial.
The supplemental value of mammographic screening over breast MRI alone in BRCA2 mutation carriers.
Obdeijn IM, Mann RM, Loo CCE, Lobbes M, Voormolen EMC, van Deurzen CHM, de Bock G; Hereditary Breast Ovarian Cancer Research Group Netherlands (HEBON); Hooning MJ. Obdeijn IM, et al. Among authors: mann rm. Breast Cancer Res Treat. 2020 Jun;181(3):581-588. doi: 10.1007/s10549-020-05642-1. Epub 2020 Apr 24. Breast Cancer Res Treat. 2020. PMID: 32333294 Free PMC article.
220 results